Antimicrobial activity and inhibition of the NorA efflux pump of Staphylococcus aureus by extract and isolated compounds from Arrabidaea brachypoda.

Autor: de Sousa Andrade LM; Laboratory of Research in Microbiology, Federal University of Piaui, Teresina, Piaui, Brazil., de Oliveira ABM; Laboratory of Research in Microbiology, Federal University of Piaui, Teresina, Piaui, Brazil., Leal ALAB; Laboratory of Research in Microbiology, Federal University of Piaui, Teresina, Piaui, Brazil., de Alcântara Oliveira FA; Laboratory of Research in Microbiology, Federal University of Piaui, Teresina, Piaui, Brazil., Portela AL; Laboratory of Advanced Studies in Phytomedicines, Federal University of Maranhão, São Luís, Maranhão, Brazil., de Sousa Lima Neto J; Laboratory of Organic Geochemistry, Federal University of Piaui, Teresina, Piauí, Brazil., de Siqueira-Júnior JP; Laboratory of Genetics of Microorganisms, Federal University of Paraiba, Joao Pessoa, Paraiba, Brazil., Kaatz GW; Department of Medicine, Division of Infectious Diseases, Wayne State University School of Medicine, Detroit, MI, USA., da Rocha CQ; Laboratory of Advanced Studies in Phytomedicines, Federal University of Maranhão, São Luís, Maranhão, Brazil., Barreto HM; Laboratory of Research in Microbiology, Federal University of Piaui, Teresina, Piaui, Brazil. Electronic address: hmbarreto@ufpi.edu.br.
Jazyk: angličtina
Zdroj: Microbial pathogenesis [Microb Pathog] 2020 Mar; Vol. 140, pp. 103935. Date of Electronic Publication: 2019 Dec 17.
DOI: 10.1016/j.micpath.2019.103935
Abstrakt: Arrabidaea brachypoda is a native shrub of the Brazilian Cerrado widely used in the folk medicine for treatment of renal diseases and articular pains. This study aimed to, first, evaluate the antimicrobial activity of both extracts and isolated molecules Brachydins BR-A and BR-B obtained from the flowers of A. brachypoda against Staphylococcus aureus, Escherchia coli and Candida albicans species. A second objective was to investigate if these natural products were able to potentiate the Norfloxacin activity against the strain Staphylococcus aureus SA1199-B that overexpress the norA gene encoding the NorA efflux pump. Extracts and isolated compounds were analyzed by HPLC-PDA and LC-ESI-MS respectively. Minimal inhibitory concentrations of Norfloxacin or Ethidium Bromide (EtBr) were determined in the presence or absence of ethanolic extract, dichloromethane fraction, as well as BR-A or BR-B by microdilution method. Only BR-B showed activity against Candida albicans. Addition of ethanolic extract, dichloromethane fraction or BR-B to the growth media at sub-inhibitory concentrations enhanced the activity of both Norfloxacin and EtBr against S. aureus SA1199-B, indicating that these natural products and its isolated compound BR-B were able to modulate the fluoroquinolone-resistance possibly by inhibition of NorA. Moreover, BR-B inhibited the EtBr efflux in the SA1199-B strain confirming that it is a NorA inhibitor. Isolated BR-B was able to inhibit an important mechanism of multidrug-resistance very prevalent in S. aureus strains, thus its use in combination with Norfloxacin could be considered as an alternative for the treatment of infections caused by S. aureus strains overexpressing norA.
Competing Interests: Declaration of competing interest The authors declare no competing financial interest.
(Copyright © 2019 Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: